A client’s recent experience applying for a European patent led to the development of a possible optimization strategy to address patent costs for clients. This client had made an initial U.S. filing ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision today vacating and remanding with ...
“Using section 1498 would not significantly reduce drug costs because, as courts have repeatedly recognized, the law requires the government to provide ‘reasonable and entire compensation’ for any ...